相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic History of Hepatitis C Virus in East Asia
Oliver G. Pybus et al.
JOURNAL OF VIROLOGY (2009)
Mechanisms of HCV survival in the host
Ella H. Sklan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Evolutionary History and Phylogeography of Human Viruses
Edward C. Holmes
ANNUAL REVIEW OF MICROBIOLOGY (2008)
Optimizing the Current Therapy for Chronic Hepatitis C Virus: Peginterferon and Ribavirin Dosing and the Utility of Growth Factors
Mitchell L. Shiffman
CLINICS IN LIVER DISEASE (2008)
Molecular and bioinformatic evidence of hepatitis C virus evolution in brain
Sarah L. Fishman et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Efficacy of interferon plus ribavirin in the treatment of hepatitis C virus genotype 5
N. Antaki et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of hepatitis C virus genotype 1 and their relationships to pegylated interferon-ribavirin treatment responses
P. Munoz de Rueda et al.
JOURNAL OF VIROLOGY (2008)
Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms
Wolf Peter Hofmann et al.
LIVER INTERNATIONAL (2008)
Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral Therapy
Nathan A. Cannon et al.
PLOS ONE (2008)
Interferon signaling and treatment outcome in chronic hepatitis C
Magdalena Sarasin-Filipowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The hepatitis C sequence database in Los Alamos
Carla Kuiken et al.
NUCLEIC ACIDS RESEARCH (2008)
Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
Olav Dalgard et al.
HEPATOLOGY (2008)
Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response
Sanaa M. Kamal et al.
HEPATOLOGY (2007)
Viral sequence evolution in acute hepatitis C virus infection
Thomas Kuntzen et al.
JOURNAL OF VIROLOGY (2007)
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
Jordan J. Feld et al.
HEPATOLOGY (2007)
Altered innate immunity in chronic hepatitis C infection: Cause or effect?
Gyongyi Szabo et al.
HEPATOLOGY (2007)
Impact of NS5A sequences of hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon-α2a plus ribavirin
Francesca Dal Pero et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution
Joerg Timm et al.
HEPATOLOGY (2007)
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3
Mitchell L. Shiffman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Analysing the evolutionary history of HCV: Puzzle of ancient phylogenetic discordance
G. Magiorkinis et al.
INFECTION GENETICS AND EVOLUTION (2007)
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C
Ming-Lung Yu et al.
GUT (2007)
GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS
Zihong Chen et al.
JOURNAL OF VIROLOGY (2007)
euHCVdb: the European hepatitis C virus database
Christophe Combet et al.
NUCLEIC ACIDS RESEARCH (2007)
Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection
Andrew R. Lloyd et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
RAxML-VI-HPC: Maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models
Alexandros Stamatakis
BIOINFORMATICS (2006)
Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race
Xiao-Song He et al.
HEPATOLOGY (2006)
Tree disagreement: Measuring and testing incongruence in phylogenies
PJ Planet
JOURNAL OF BIOMEDICAL INFORMATICS (2006)
Response of hepatitis C genotype-4 naive patients to 24 weeks of peg-interferon-α2b/ribavirin or induction-dose interferon-α2b/ribavirin/amantadine:: A non-randomized controlled study
AR El-Zayadi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
P Simmonds et al.
HEPATOLOGY (2005)
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
JJ Feld et al.
NATURE (2005)
Evasion of intracellular host defence by hepatitis C virus
M Gale et al.
NATURE (2005)
Peginterferon-α-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C
M von Wagner et al.
GASTROENTEROLOGY (2005)
HCV genotype 2 as a risk factor for reactivation of chronic HCV infection
N Coppola et al.
GUT (2005)
Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis
M Derbala et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3
A Mangia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cellular immune selection with hepatitis C virus persistence in humans
AL Cox et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Divergent and convergent evolution after a common-source outbreak of hepatitis C virus
SC Ray et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Peginterferon α-2b and ribavirin therapy in chronic hepatitis C genotype 4:: impact of treatment duration and viral kinetics on sustained virological response
SM Kamal et al.
GUT (2005)
Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients
MG Rumi et al.
GUT (2005)
HyPhy: hypothesis testing using phylogenies
SLK Pond et al.
BIOINFORMATICS (2005)
Mutations within the hepatitis C virus genotype 1b E2-PePHD domain do not correlate with treatment outcome
C Gaudy et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1NK5.1)
M Miyamoto et al.
INTERVIROLOGY (2005)
MAFFT version 5: improvement in accuracy of multiple sequence alignment
K Katoh et al.
NUCLEIC ACIDS RESEARCH (2005)
Host factors and failure of interferon-α treatment in hepatitis C virus
B Gao et al.
HEPATOLOGY (2004)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Steatosis affects chronic hepatitis C progression in a genotype specific way
L Rubbia-Brandt et al.
GUT (2004)
Unifying the epidemiological and evolutionary dynamics of pathogens
BT Grenfell et al.
SCIENCE (2004)
Detection of genome-scale ordered RNA structure (GORS) in genomes of positive-stranded RNA viruses: Implications for virus evolution and host persistence
P Simmonds et al.
RNA (2004)
Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
F Hasan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection
SI Khakoo et al.
SCIENCE (2004)
Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4
FZ Alfaleh et al.
LIVER INTERNATIONAL (2004)
Genetic diversity and evolution of hepatitis C virus - 15 years on
P Simmonds
JOURNAL OF GENERAL VIROLOGY (2004)
Sensitivity of hepatitis C virus RNA to the antiviral enzyme ribonuclease L is determined by a subset of efficient cleavage sites
JQ Han et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2004)
Performance of maximum parsimony and likelihood phylogenetics when evolution is heterogeneous
B Kolaczkowski et al.
NATURE (2004)
Protein-protein interactions between hepatitis C virus nonstructural proteins
M Dimitrova et al.
JOURNAL OF VIROLOGY (2003)
Peginterferon alone or with ribavirin enhances HCV-specific CD4+ T-helper 1 responses in patients with chronic hepatitis C
SM Kamal et al.
GASTROENTEROLOGY (2002)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Viruses and interferon: A fight for supremacy
MG Katze et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Increased taxon sampling greatly reduces phylogenetic error
DJ Zwickl et al.
SYSTEMATIC BIOLOGY (2002)
An approximately unbiased test of phylogenetic tree selection
H Shimodaira
SYSTEMATIC BIOLOGY (2002)
Activation and evasion of the antiviral 2′-5′ oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA
JQ Han et al.
RNA (2002)
Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences
M Salemi et al.
JOURNAL OF MOLECULAR EVOLUTION (2002)
CONSEL: for assessing the confidence of phylogenetic tree selection
H Shimodaira et al.
BIOINFORMATICS (2001)
Treatment of acute hepatitis C with interferon alfa-2b
E Jaeckel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
The epidemic behavior of the hepatitis C virus
OG Pybus et al.
SCIENCE (2001)
Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells
T Noguchi et al.
MICROBIOLOGY AND IMMUNOLOGY (2001)
Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment
T Berg et al.
HEPATOLOGY (2000)
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies
P Farci et al.
SCIENCE (2000)
分享论文
